Valsartan Drug Market Report

Global and Regional Valsartan Drug Market Details Research Report 2021-2026

  • POSTDATE：Jun 24, 2021
  • PAGES：221
  • REPORT CODE：GMM711442
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Valsartan Drug Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Valsartan Drug market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Valsartan Drug market.

    By Player:

    • Amneal Pharmaceuticals

    • Teva

    • Torrent Pharmaceuticals

    • Lupin

    • Aurobindo Pharma

    • Unichem Laboratories

    • HETERO

    • Alembic Pharmaceuticals

    • Square Pharmaceuticals

    • Huaren Pharmaceutical

    • Sun Pharmaceutical

    • Zhejiang Huahai Pharmaceutical

    • Jubilant Pharma

    • Novartis

    • Mylan

    • Macleods Pharmaceuticals

    By Type:

    • 40 mg Tablets

    • 80 mg Tablets

    • 160 mg Tablets

    • 320 mg Tablets

    By End-User:

    • Hypertension

    • Heart Failure

    • Heart Attack

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Valsartan Drug Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Valsartan Drug Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Valsartan Drug Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Valsartan Drug Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Valsartan Drug Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Valsartan Drug Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Amneal Pharmaceuticals

      • 3.1.1 Amneal Pharmaceuticals - Company Business Overview

      • 3.1.2 Amneal Pharmaceuticals - Company Financial Performance

      • 3.1.3 Amneal Pharmaceuticals - Company Financial Performance of Valsartan Drug

      • 3.1.4 Valsartan Drug Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 Teva

      • 3.2.1 Teva - Company Business Overview

      • 3.2.2 Teva - Company Financial Performance

      • 3.2.3 Teva - Company Financial Performance of Valsartan Drug

      • 3.2.4 Valsartan Drug Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 Torrent Pharmaceuticals

      • 3.3.1 Torrent Pharmaceuticals - Company Business Overview

      • 3.3.2 Torrent Pharmaceuticals - Company Financial Performance

      • 3.3.3 Torrent Pharmaceuticals - Company Financial Performance of Valsartan Drug

      • 3.3.4 Valsartan Drug Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 Lupin

      • 3.4.1 Lupin - Company Business Overview

      • 3.4.2 Lupin - Company Financial Performance

      • 3.4.3 Lupin - Company Financial Performance of Valsartan Drug

      • 3.4.4 Valsartan Drug Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 Aurobindo Pharma

      • 3.5.1 Aurobindo Pharma - Company Business Overview

      • 3.5.2 Aurobindo Pharma - Company Financial Performance

      • 3.5.3 Aurobindo Pharma - Company Financial Performance of Valsartan Drug

      • 3.5.4 Valsartan Drug Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 Unichem Laboratories

      • 3.6.1 Unichem Laboratories - Company Business Overview

      • 3.6.2 Unichem Laboratories - Company Financial Performance

      • 3.6.3 Unichem Laboratories - Company Financial Performance of Valsartan Drug

      • 3.6.4 Valsartan Drug Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 HETERO

      • 3.7.1 HETERO - Company Business Overview

      • 3.7.2 HETERO - Company Financial Performance

      • 3.7.3 HETERO - Company Financial Performance of Valsartan Drug

      • 3.7.4 Valsartan Drug Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 Alembic Pharmaceuticals

      • 3.8.1 Alembic Pharmaceuticals - Company Business Overview

      • 3.8.2 Alembic Pharmaceuticals - Company Financial Performance

      • 3.8.3 Alembic Pharmaceuticals - Company Financial Performance of Valsartan Drug

      • 3.8.4 Valsartan Drug Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 Square Pharmaceuticals

      • 3.9.1 Square Pharmaceuticals - Company Business Overview

      • 3.9.2 Square Pharmaceuticals - Company Financial Performance

      • 3.9.3 Square Pharmaceuticals - Company Financial Performance of Valsartan Drug

      • 3.9.4 Valsartan Drug Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 Huaren Pharmaceutical

      • 3.10.1 Huaren Pharmaceutical - Company Business Overview

      • 3.10.2 Huaren Pharmaceutical - Company Financial Performance

      • 3.10.3 Huaren Pharmaceutical - Company Financial Performance of Valsartan Drug

      • 3.10.4 Valsartan Drug Product Benchmarking

      • 3.10.5 Strategic Initiatives

    • 3.11 Sun Pharmaceutical

      • 3.11.1 Sun Pharmaceutical - Company Business Overview

      • 3.11.2 Sun Pharmaceutical - Company Financial Performance

      • 3.11.3 Sun Pharmaceutical - Company Financial Performance of Valsartan Drug

      • 3.11.4 Valsartan Drug Product Benchmarking

      • 3.11.5 Strategic Initiatives

    • 3.12 Zhejiang Huahai Pharmaceutical

      • 3.12.1 Zhejiang Huahai Pharmaceutical - Company Business Overview

      • 3.12.2 Zhejiang Huahai Pharmaceutical - Company Financial Performance

      • 3.12.3 Zhejiang Huahai Pharmaceutical - Company Financial Performance of Valsartan Drug

      • 3.12.4 Valsartan Drug Product Benchmarking

      • 3.12.5 Strategic Initiatives

    • 3.13 Jubilant Pharma

      • 3.13.1 Jubilant Pharma - Company Business Overview

      • 3.13.2 Jubilant Pharma - Company Financial Performance

      • 3.13.3 Jubilant Pharma - Company Financial Performance of Valsartan Drug

      • 3.13.4 Valsartan Drug Product Benchmarking

      • 3.13.5 Strategic Initiatives

    • 3.14 Novartis

      • 3.14.1 Novartis - Company Business Overview

      • 3.14.2 Novartis - Company Financial Performance

      • 3.14.3 Novartis - Company Financial Performance of Valsartan Drug

      • 3.14.4 Valsartan Drug Product Benchmarking

      • 3.14.5 Strategic Initiatives

    • 3.15 Mylan

      • 3.15.1 Mylan - Company Business Overview

      • 3.15.2 Mylan - Company Financial Performance

      • 3.15.3 Mylan - Company Financial Performance of Valsartan Drug

      • 3.15.4 Valsartan Drug Product Benchmarking

      • 3.15.5 Strategic Initiatives

    • 3.16 Macleods Pharmaceuticals

      • 3.16.1 Macleods Pharmaceuticals - Company Business Overview

      • 3.16.2 Macleods Pharmaceuticals - Company Financial Performance

      • 3.16.3 Macleods Pharmaceuticals - Company Financial Performance of Valsartan Drug

      • 3.16.4 Valsartan Drug Product Benchmarking

      • 3.16.5 Strategic Initiatives

    4 Global Valsartan Drug Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Valsartan Drug Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of 40 mg Tablets 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of 80 mg Tablets 2016-2021

      • 4.2.3 Global Revenue and Growth Rate of 160 mg Tablets 2016-2021

      • 4.2.4 Global Revenue and Growth Rate of 320 mg Tablets 2016-2021

    • 4.3 Global Valsartan Drug Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of 40 mg Tablets 2016-2021

      • 4.3.2 Global Sales and Growth Rate of 80 mg Tablets 2016-2021

      • 4.3.3 Global Sales and Growth Rate of 160 mg Tablets 2016-2021

      • 4.3.4 Global Sales and Growth Rate of 320 mg Tablets 2016-2021

    • 4.4 Global Valsartan Drug Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Valsartan Drug Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Valsartan Drug Market Price By Type from 2016 to 2026

    5 Global Valsartan Drug Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Valsartan Drug

    • 5.2 Global Valsartan Drug Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Hypertension 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Heart Failure 2016-2021

      • 5.2.3 Global Revenue and Growth Rate of Heart Attack 2016-2021

    • 5.3 Global Valsartan Drug Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Hypertension 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Heart Failure 2016-2021

      • 5.3.3 Global Sales and Growth Rate of Heart Attack 2016-2021

    • 5.4 Global Valsartan Drug Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Valsartan Drug Market Sales and Market Share by Application (Forecast)

    6 Global Valsartan Drug Market Segment Analysis (Geography Level)

    • 6.1 Global Valsartan Drug Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Valsartan Drug Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Valsartan Drug Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Valsartan Drug Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Valsartan Drug Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Valsartan Drug Market from 2016 to 2020

    7. North America Valsartan Drug Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Valsartan Drug Market Segment by Countries

      • 7.1.1 North America Valsartan Drug Market Revenue Segment by Countries

      • 7.1.2 North America Valsartan Drug Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Valsartan Drug Market Segment (Product Type Level)

    • 7.3 North America Valsartan Drug Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Valsartan Drug Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Valsartan Drug Market Segment by Countries

      • 8.1.1 Europe Valsartan Drug Market Revenue Segment by Countries

      • 8.1.2 Europe Valsartan Drug Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Valsartan Drug Market Segment (Product Type Level)

    • 8.3 Europe Valsartan Drug Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Valsartan Drug Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Valsartan Drug Market Segment by Countries

      • 9.1.1 Asia Valsartan Drug Market Revenue Segment by Countries

      • 9.1.2 Asia Valsartan Drug Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Valsartan Drug Market Segment (Product Type Level)

    • 9.3 Asia Valsartan Drug Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Valsartan Drug Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Valsartan Drug Market Segment by Countries

      • 10.1.1 South America Valsartan Drug Market Revenue Segment by Countries

      • 10.1.2 South America Valsartan Drug Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Valsartan Drug Market Segment (Product Type Level)

    • 10.3 South America Valsartan Drug Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Valsartan Drug Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Valsartan Drug Market Segment by Countries

      • 11.1.1 Middle East Valsartan Drug Market Revenue Segment by Countries

      • 11.1.2 Middle East Valsartan Drug Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Valsartan Drug Market Segment (Product Type Level)

    • 11.3 Middle East Valsartan Drug Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Valsartan Drug Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Valsartan Drug Market Segment by Countries

      • 12.1.1 Africa Valsartan Drug Market Revenue Segment by Countries

      • 12.1.2 Africa Valsartan Drug Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Valsartan Drug Market Segment (Product Type Level)

    • 12.3 Africa Valsartan Drug Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Valsartan Drug Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Valsartan Drug Market Segment by Countries

      • 13.1.1 Oceania Valsartan Drug Market Revenue Segment by Countries

      • 13.1.2 Oceania Valsartan Drug Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Valsartan Drug Market Segment (Product Type Level)

    • 13.3 Oceania Valsartan Drug Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Valsartan Drug Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Valsartan Drug

      • 14.2.2 Manufacturing Process Analysis of Valsartan Drug

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Valsartan Drug Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Valsartan Drug Industry Market Status, Pre-COVID-19

      • 15.5.3 Valsartan Drug Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Valsartan Drug Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Valsartan Drug Product Picture

    • Table Valsartan Drug Product Definition

    • Table Study Scope by Types

    • Figure Global Valsartan Drug Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Valsartan Drug Market Value by Application (2016 - 2026)

    • Figure Global Valsartan Drug Market Size and Growth Rate from 2016 to 2026

    • Table Global Valsartan Drug Production Capacity by Manufacturers (2016-2021)

    • Table Global Valsartan Drug Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Valsartan Drug Revenue by Manufacturers (2016-2021)

    • Table Global Valsartan Drug Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Valsartan Drug Plant Distribution and Sales Country

    • Table Amneal Pharmaceuticals - Company Business Overview

    • Figure Amneal Pharmaceuticals Total Revenue from 2018 to 2020

    • Table Amneal Pharmaceuticals Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Amneal Pharmaceuticals Sales and Growth Rate Analysis of Valsartan Drug

    • Figure Revenue and Market Share Analysis of Amneal Pharmaceuticals

    • Table Valsartan Drug Product Benchmarking

    • Table Teva - Company Business Overview

    • Figure Teva Total Revenue from 2018 to 2020

    • Table Teva Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Teva Sales and Growth Rate Analysis of Valsartan Drug

    • Figure Revenue and Market Share Analysis of Teva

    • Table Valsartan Drug Product Benchmarking

    • Table Torrent Pharmaceuticals - Company Business Overview

    • Figure Torrent Pharmaceuticals Total Revenue from 2018 to 2020

    • Table Torrent Pharmaceuticals Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Torrent Pharmaceuticals Sales and Growth Rate Analysis of Valsartan Drug

    • Figure Revenue and Market Share Analysis of Torrent Pharmaceuticals

    • Table Valsartan Drug Product Benchmarking

    • Table Lupin - Company Business Overview

    • Figure Lupin Total Revenue from 2018 to 2020

    • Table Lupin Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Lupin Sales and Growth Rate Analysis of Valsartan Drug

    • Figure Revenue and Market Share Analysis of Lupin

    • Table Valsartan Drug Product Benchmarking

    • Table Aurobindo Pharma - Company Business Overview

    • Figure Aurobindo Pharma Total Revenue from 2018 to 2020

    • Table Aurobindo Pharma Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Aurobindo Pharma Sales and Growth Rate Analysis of Valsartan Drug

    • Figure Revenue and Market Share Analysis of Aurobindo Pharma

    • Table Valsartan Drug Product Benchmarking

    • Table Unichem Laboratories - Company Business Overview

    • Figure Unichem Laboratories Total Revenue from 2018 to 2020

    • Table Unichem Laboratories Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Unichem Laboratories Sales and Growth Rate Analysis of Valsartan Drug

    • Figure Revenue and Market Share Analysis of Unichem Laboratories

    • Table Valsartan Drug Product Benchmarking

    • Table HETERO - Company Business Overview

    • Figure HETERO Total Revenue from 2018 to 2020

    • Table HETERO Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure HETERO Sales and Growth Rate Analysis of Valsartan Drug

    • Figure Revenue and Market Share Analysis of HETERO

    • Table Valsartan Drug Product Benchmarking

    • Table Alembic Pharmaceuticals - Company Business Overview

    • Figure Alembic Pharmaceuticals Total Revenue from 2018 to 2020

    • Table Alembic Pharmaceuticals Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Alembic Pharmaceuticals Sales and Growth Rate Analysis of Valsartan Drug

    • Figure Revenue and Market Share Analysis of Alembic Pharmaceuticals

    • Table Valsartan Drug Product Benchmarking

    • Table Square Pharmaceuticals - Company Business Overview

    • Figure Square Pharmaceuticals Total Revenue from 2018 to 2020

    • Table Square Pharmaceuticals Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Square Pharmaceuticals Sales and Growth Rate Analysis of Valsartan Drug

    • Figure Revenue and Market Share Analysis of Square Pharmaceuticals

    • Table Valsartan Drug Product Benchmarking

    • Table Huaren Pharmaceutical - Company Business Overview

    • Figure Huaren Pharmaceutical Total Revenue from 2018 to 2020

    • Table Huaren Pharmaceutical Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Huaren Pharmaceutical Sales and Growth Rate Analysis of Valsartan Drug

    • Figure Revenue and Market Share Analysis of Huaren Pharmaceutical

    • Table Valsartan Drug Product Benchmarking

    • Table Sun Pharmaceutical - Company Business Overview

    • Figure Sun Pharmaceutical Total Revenue from 2018 to 2020

    • Table Sun Pharmaceutical Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Sun Pharmaceutical Sales and Growth Rate Analysis of Valsartan Drug

    • Figure Revenue and Market Share Analysis of Sun Pharmaceutical

    • Table Valsartan Drug Product Benchmarking

    • Table Zhejiang Huahai Pharmaceutical - Company Business Overview

    • Figure Zhejiang Huahai Pharmaceutical Total Revenue from 2018 to 2020

    • Table Zhejiang Huahai Pharmaceutical Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Zhejiang Huahai Pharmaceutical Sales and Growth Rate Analysis of Valsartan Drug

    • Figure Revenue and Market Share Analysis of Zhejiang Huahai Pharmaceutical

    • Table Valsartan Drug Product Benchmarking

    • Table Jubilant Pharma - Company Business Overview

    • Figure Jubilant Pharma Total Revenue from 2018 to 2020

    • Table Jubilant Pharma Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Jubilant Pharma Sales and Growth Rate Analysis of Valsartan Drug

    • Figure Revenue and Market Share Analysis of Jubilant Pharma

    • Table Valsartan Drug Product Benchmarking

    • Table Novartis - Company Business Overview

    • Figure Novartis Total Revenue from 2018 to 2020

    • Table Novartis Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Novartis Sales and Growth Rate Analysis of Valsartan Drug

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Valsartan Drug Product Benchmarking

    • Table Mylan - Company Business Overview

    • Figure Mylan Total Revenue from 2018 to 2020

    • Table Mylan Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Mylan Sales and Growth Rate Analysis of Valsartan Drug

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Valsartan Drug Product Benchmarking

    • Table Macleods Pharmaceuticals - Company Business Overview

    • Figure Macleods Pharmaceuticals Total Revenue from 2018 to 2020

    • Table Macleods Pharmaceuticals Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Macleods Pharmaceuticals Sales and Growth Rate Analysis of Valsartan Drug

    • Figure Revenue and Market Share Analysis of Macleods Pharmaceuticals

    • Table Valsartan Drug Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Valsartan Drug Market Revenue by Types (Historical)

    • Table Global Valsartan Drug Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of 40 mg Tablets 2016-2021

    • Figure Global Revenue and Growth Rate of 80 mg Tablets 2016-2021

    • Figure Global Revenue and Growth Rate of 160 mg Tablets 2016-2021

    • Figure Global Revenue and Growth Rate of 320 mg Tablets 2016-2021

    • Table Global Valsartan Drug Market Sales by Types (Historical)

    • Table Global Valsartan Drug Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of 40 mg Tablets 2016-2021

    • Figure Global Sales and Growth Rate of 80 mg Tablets 2016-2021

    • Figure Global Sales and Growth Rate of 160 mg Tablets 2016-2021

    • Figure Global Sales and Growth Rate of 320 mg Tablets 2016-2021

    • Table Global Valsartan Drug Market Revenue by Types (Forecast)

    • Table Global Valsartan Drug Market Revenue Market Share by Types (Forecast)

    • Table Global Valsartan Drug Market Sales by Types (Forecast)

    • Table Global Valsartan Drug Market Sales Market Share by Types (Forecast)

    • Figure Global Valsartan Drug Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Valsartan Drug

    • Table Global Valsartan Drug Market Revenue by Application (Historical)

    • Table Global Valsartan Drug Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Hypertension 2016-2021

    • Figure Global Revenue and Growth Rate of Heart Failure 2016-2021

    • Figure Global Revenue and Growth Rate of Heart Attack 2016-2021

    • Table Global Valsartan Drug Market Sales by Application (Historical)

    • Table Global Valsartan Drug Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Hypertension 2016-2021

    • Figure Global Sales and Growth Rate of Heart Failure 2016-2021

    • Figure Global Sales and Growth Rate of Heart Attack 2016-2021

    • Table Global Valsartan Drug Market Revenue by Application (Forecast)

    • Table Global Valsartan Drug Market Revenue Market Share by Application (Forecast)

    • Table Global Valsartan Drug Market Sales by Application (Forecast)

    • Table Global Valsartan Drug Market Sales Market Share by Application (Forecast)

    • Table Global Valsartan Drug Market Revenue by Geography (Historical)

    • Table Global Valsartan Drug Market Revenue Market Share by Geography (Historical)

    • Figure Global Valsartan Drug Revenue Market Share by Geography in 2020

    • Table Global Valsartan Drug Market Sales by Geography (Historical)

    • Table Global Valsartan Drug Market Sales Market Share by Geography (Historical)

    • Figure Global Valsartan Drug Sales Market Share by Geography in 2020

    • Table Global Valsartan Drug Market Revenue by Geography (Forecast)

    • Table Global Valsartan Drug Market Revenue Market Share by Geography (Forecast)

    • Table Global Valsartan Drug Market Sales by Geography (Forecast)

    • Table Global Valsartan Drug Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Valsartan Drug Revenue by Countries from 2016 to 2026

    • Table North America Valsartan Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Valsartan Drug Revenue Market Share by Major Countries in 2020

    • Table North America Valsartan Drug Sales by Countries from 2016 to 2026

    • Table North America Valsartan Drug Sales Market Share by Countries from 2016 to 2026

    • Figure North America Valsartan Drug Sales Market Share by Major Countries in 2020

    • Figure USA Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure USA Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Table North America Valsartan Drug Sales by Types from 2016 to 2026

    • Table North America Valsartan Drug Sales Market Share by Types from 2016 to 2026

    • Table North America Valsartan Drug Value by Types from 2016 to 2026

    • Table North America Valsartan Drug Value Market Share by Types from 2016 to 2026

    • Table North America Valsartan Drug Sales by Application from 2016 to 2026

    • Table North America Valsartan Drug Sales Market Share by Application from 2016 to 2026

    • Table North America Valsartan Drug Value by Application from 2016 to 2026

    • Table North America Valsartan Drug Value Market Share by Application from 2016 to 2026

    • Table Europe Valsartan Drug Revenue by Countries from 2016 to 2026

    • Table Europe Valsartan Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Valsartan Drug Revenue Market Share by Major Countries in 2020

    • Table Europe Valsartan Drug Sales by Countries from 2016 to 2026

    • Table Europe Valsartan Drug Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Valsartan Drug Sales Market Share by Major Countries in 2020

    • Figure Germany Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure France Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure France Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Valsartan Drug Sales by Types from 2016 to 2026

    • Table Europe Valsartan Drug Sales Market Share by Types from 2016 to 2026

    • Table Europe Valsartan Drug Value by Types from 2016 to 2026

    • Table Europe Valsartan Drug Value Market Share by Types from 2016 to 2026

    • Table Europe Valsartan Drug Sales by Application from 2016 to 2026

    • Table Europe Valsartan Drug Sales Market Share by Application from 2016 to 2026

    • Table Europe Valsartan Drug Value by Application from 2016 to 2026

    • Table Europe Valsartan Drug Value Market Share by Application from 2016 to 2026

    • Table Asia Valsartan Drug Revenue by Countries from 2016 to 2026

    • Table Asia Valsartan Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Valsartan Drug Revenue Market Share by Major Countries in 2020

    • Table Asia Valsartan Drug Sales by Countries from 2016 to 2026

    • Table Asia Valsartan Drug Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Valsartan Drug Sales Market Share by Major Countries in 2020

    • Figure China Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure China Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure India Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure India Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Valsartan Drug Sales by Types from 2016 to 2026

    • Table Asia Valsartan Drug Sales Market Share by Types from 2016 to 2026

    • Table Asia Valsartan Drug Value by Types from 2016 to 2026

    • Table Asia Valsartan Drug Value Market Share by Types from 2016 to 2026

    • Table Asia Valsartan Drug Sales by Application from 2016 to 2026

    • Table Asia Valsartan Drug Sales Market Share by Application from 2016 to 2026

    • Table Asia Valsartan Drug Value by Application from 2016 to 2026

    • Table Asia Valsartan Drug Value Market Share by Application from 2016 to 2026

    • Table South America Valsartan Drug Revenue by Countries from 2016 to 2026

    • Table South America Valsartan Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Valsartan Drug Revenue Market Share by Major Countries in 2020

    • Table South America Valsartan Drug Sales by Countries from 2016 to 2026

    • Table South America Valsartan Drug Sales Market Share by Countries from 2016 to 2026

    • Figure South America Valsartan Drug Sales Market Share by Major Countries in 2020

    • Figure Brazil Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Table South America Valsartan Drug Sales by Types from 2016 to 2026

    • Table South America Valsartan Drug Sales Market Share by Types from 2016 to 2026

    • Table South America Valsartan Drug Value by Types from 2016 to 2026

    • Table South America Valsartan Drug Value Market Share by Types from 2016 to 2026

    • Table South America Valsartan Drug Sales by Application from 2016 to 2026

    • Table South America Valsartan Drug Sales Market Share by Application from 2016 to 2026

    • Table South America Valsartan Drug Value by Application from 2016 to 2026

    • Table South America Valsartan Drug Value Market Share by Application from 2016 to 2026

    • Table Middle East Valsartan Drug Revenue by Countries from 2016 to 2026

    • Table Middle East Valsartan Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Valsartan Drug Revenue Market Share by Major Countries in 2020

    • Table Middle East Valsartan Drug Sales by Countries from 2016 to 2026

    • Table Middle East Valsartan Drug Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Valsartan Drug Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Valsartan Drug Sales by Types from 2016 to 2026

    • Table Middle East Valsartan Drug Sales Market Share by Types from 2016 to 2026

    • Table Middle East Valsartan Drug Value by Types from 2016 to 2026

    • Table Middle East Valsartan Drug Value Market Share by Types from 2016 to 2026

    • Table Middle East Valsartan Drug Sales by Application from 2016 to 2026

    • Table Middle East Valsartan Drug Sales Market Share by Application from 2016 to 2026

    • Table Middle East Valsartan Drug Value by Application from 2016 to 2026

    • Table Middle East Valsartan Drug Value Market Share by Application from 2016 to 2026

    • Table Africa Valsartan Drug Revenue by Countries from 2016 to 2026

    • Table Africa Valsartan Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Valsartan Drug Revenue Market Share by Major Countries in 2020

    • Table Africa Valsartan Drug Sales by Countries from 2016 to 2026

    • Table Africa Valsartan Drug Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Valsartan Drug Sales Market Share by Major Countries in 2020

    • Figure Nigeria Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Valsartan Drug Sales by Types from 2016 to 2026

    • Table Africa Valsartan Drug Sales Market Share by Types from 2016 to 2026

    • Table Africa Valsartan Drug Value by Types from 2016 to 2026

    • Table Africa Valsartan Drug Value Market Share by Types from 2016 to 2026

    • Table Africa Valsartan Drug Sales by Application from 2016 to 2026

    • Table Africa Valsartan Drug Sales Market Share by Application from 2016 to 2026

    • Table Africa Valsartan Drug Value by Application from 2016 to 2026

    • Table Africa Valsartan Drug Value Market Share by Application from 2016 to 2026

    • Table Oceania Valsartan Drug Revenue by Countries from 2016 to 2026

    • Table Oceania Valsartan Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Valsartan Drug Revenue Market Share by Major Countries in 2020

    • Table Oceania Valsartan Drug Sales by Countries from 2016 to 2026

    • Table Oceania Valsartan Drug Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Valsartan Drug Sales Market Share by Major Countries in 2020

    • Figure Australia Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Valsartan Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others Valsartan Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Valsartan Drug Sales by Types from 2016 to 2026

    • Table Oceania Valsartan Drug Sales Market Share by Types from 2016 to 2026

    • Table Oceania Valsartan Drug Value by Types from 2016 to 2026

    • Table Oceania Valsartan Drug Value Market Share by Types from 2016 to 2026

    • Table Oceania Valsartan Drug Sales by Application from 2016 to 2026

    • Table Oceania Valsartan Drug Sales Market Share by Application from 2016 to 2026

    • Table Oceania Valsartan Drug Value by Application from 2016 to 2026

    • Table Oceania Valsartan Drug Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Valsartan Drug

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Valsartan Drug with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US